Zevra Therapeutics (NASDAQ:ZVRA) Price Target Raised to $25.00
Zevra Therapeutics (NASDAQ:ZVRA – Free Report) had its target price boosted by Canaccord Genuity Group from $23.00 to $25.00 in a research note issued to investors on Thursday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other research firms also recently commented on ZVRA. Citigroup restated an “outperform” rating on […]
Zevra Therapeutics (NASDAQ:ZVRA – Free Report) had its target price boosted by Canaccord Genuity Group from $23.00 to $25.00 in a research note issued to investors on Thursday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other research firms also recently commented on ZVRA. Citigroup restated an “outperform” rating on […]
